{
  "patent_number": "US 12735386",
  "country": "US",
  "title": "New Psilocybin-Like Drugs for Brain Receptor Diseases",
  "original_title": "Psilocybin analogs, salts, compositions, and methods of use",
  "summary": "This patent describes new chemical compounds similar to psilocin, found in 'magic mushrooms,' designed to activate specific brain receptors for treating various diseases.",
  "what_it_does": "This patent focuses on creating new chemical compounds, referred to as \"psilocin compounds\" or \"analogs,\" that are chemically similar to psilocin. These compounds are designed to act as \"serotonin 5-HT2 receptor agonists,\" meaning they activate specific serotonin receptors in the brain. The goal is to use these new compounds in \"pharmaceutical compositions\" to treat medical conditions associated with these 5-HT2 receptors. For example, a new psilocin analog could be formulated into a pill to treat a mental health condition like depression, aiming to provide therapeutic benefits by modulating brain activity through these specific receptors. Due to the lack of available claims text, specific claim elements cannot be referenced.",
  "what_it_does_not_cover": [
    "Does not cover natural psilocybin or psilocin compounds, only their specific synthetic 'analogs' or derivatives.",
    "Does not cover compounds that do not primarily function as 'serotonin 5-HT2 receptor agonists'.",
    "Does not cover non-chemical or non-pharmaceutical treatments for diseases associated with 5-HT2 receptors.",
    "Does not cover methods of use that are not for the treatment of diseases."
  ],
  "filed": "2022-03-17",
  "granted": "2026-09-15",
  "expires": null,
  "status": "active",
  "holder": null,
  "holder_url": null,
  "inventors": [],
  "times_cited": 0,
  "tags": [
    "biotech",
    "pharmaceutical",
    "neuroscience"
  ],
  "abstract": "The present disclosure relates to psilocin compounds and pharmaceutically acceptable salts, polymorphs, stereoisomers, or solvates thereof, to pharmaceutical compositions, and in some embodiments, to serotonin 5-HT 2  receptor agonists and uses in the treatment of diseases associated with a 5-HT 2  receptor.",
  "url": "https://patentbrief.org/patent/us/12735386/psilocybin-analogs-salts-compositions-and-methods-of-use",
  "markdown_url": "https://patentbrief.org/patent/us/12735386/psilocybin-analogs-salts-compositions-and-methods-of-use/md",
  "google_patents_url": "https://patents.google.com/patent/US12735386",
  "relatedPatents": [
    {
      "patentNumber": "12735425",
      "countryCode": "US",
      "title": "Chemical Compounds to Block a Specific KRAS Cancer Gene",
      "url": "https://patentbrief.org/patent/us/12735425/67-dihydro-pyrano23-dpyrimidine-inhibitors-of-kras-g12c-mutant"
    },
    {
      "patentNumber": "12733635",
      "countryCode": "US",
      "title": "Improving How Blood Platelets Are Stored",
      "url": "https://patentbrief.org/patent/us/12733635/platelet-storage-methods-and-compositions"
    },
    {
      "patentNumber": "12734174",
      "countryCode": "US",
      "title": "Treating Lewy Body Dementia by Targeting Patients Without Tau Protein",
      "url": "https://patentbrief.org/patent/us/12734174/treatment-of-a-selective-population-of-patients-having-dementia-with-lewy-bodies"
    },
    {
      "patentNumber": "12735703",
      "countryCode": "US",
      "title": "How Oligonucleotides Target C9orf72 for Brain Diseases",
      "url": "https://patentbrief.org/patent/us/12735703/oligonucleotide-compositions-and-methods-of-use-thereof"
    },
    {
      "patentNumber": "12734191",
      "countryCode": "US",
      "title": "Treating Niemann-Pick Type C with a Special Sugar Mixture",
      "url": "https://patentbrief.org/patent/us/12734191/hydroxypropyl-beta-cyclodextrin-compositions-and-methods-12734191"
    }
  ]
}